ANti-Oxidant in Variant Angina (ANOVA) Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 320 participants.
Also called NCT03228238
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 320 participants
- Registry
-
NCT03228238
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Terminated
Technical summary
Registry record NCT03228238. Randomized; no masking; primary purpose treatment. Start 2014-09-01 (actual); primary completion 2024-06-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ANti-Oxidant in Variant Angina (ANOVA) Trial
- Condition
- Variant Angina
- Intervention (Drug)
- Vitamin C and Vitamin E
- Intervention (Drug)
- Statin
- Intervention (Drug)
- Standard medication for variant angina
- Lead sponsor
- Seoul National University Hospital
Record details
- Record id
cardio:ct-nct03228238- Content hash
9e19f9a18cd8d3babc49f5f1f60f88ae1f68c2539c77ed2c718a6517e6efe9b7